Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study

Go back to Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study
(NASDAQ: BDSX) Delayed: 26.97 +0.93 (3.57%)
Previous Close $26.04    52 Week High
Open $26.12    52 Week Low
Day High $27.14    P/E N/A 
Day Low $25.82    EPS
Volume 46,440